Epiphany Announces Positive Results From Its Phase 2b Trial In Shingles
Links shared publicly online about this topic.
- 1,591total visits
Epiphany Announces Positive Results From Its Phase 2b Trial In Shingles
Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection. The study's primary endpoint was non-in
View full resource at medicalnewstoday.com
Tags: Infection, Shingles, STD, Herpes
Most Recently Shared on November 19, 2009 at 3:14 pm By:
Epiphany Announces Positive Results From Its Phase 2b Trial In Shingles: Epiphany Biosciences announced results.. http://bit.ly/31yZDH
Advertisement
